Overview
BIOVECTRA is a global full-service CDMO specializing in small molecules, biologics, bioreagents, pDNA, and mRNA manufacturing for pharma and biotech. They provide end-to-end services from process development and cGMP production at kilo lab, pilot, and commercial scales to analytical testing and sterile fill-finish. Capabilities include microbial fermentation, synthetic chemistry, high potency containment, and lipid nanoparticle formulation, supporting projects from early clinical to commercial supply.
Frequently asked questions
- What manufacturing capabilities does BIOVECTRA offer?
- BIOVECTRA provides cGMP CDMO services for small molecules via synthetic chemistry and microbial fermentation, biologics including proteins, enzymes, peptides, pDNA, mRNA, and lipid nanoparticles, plus sterile fill-finish across kilo lab, pilot, and commercial scales.
- What regulatory support and compliance does BIOVECTRA provide?
- BIOVECTRA supports GMP and CMC requirements with phase-appropriate analytical testing, method development/validation, process characterization, validation support, and Quality by Design strategies for small molecule APIs and biologic drug substances.
- What geographies does BIOVECTRA serve?
- BIOVECTRA serves biotech and pharmaceutical companies primarily in North America and Europe, with global CDMO operations based in Canada offering unique mRNA and pDNA capabilities.